Alzheimer's gene associated with failure to adapt to cognitive challenge in healthy adults

by Society for NeuroscienceHealthy adults carrying the gene APOE4—the strongest known genetic risk factor for Alzheimer's disease (AD)—may struggle to adapt their brain activity to increasing

Updated on: March 07,2024

Alzheimer's gene associated with failure to adapt to cognitive challenge in healthy adults

by Society for NeuroscienceHealthy adults carrying the gene APOE4—the strongest known genetic risk factor for Alzheimer's disease (AD)—may struggle to adapt their brain activity to increasing

Updated on:March 07,2024

Is that 'midlife crisis' really Alzheimer's disease?

by Carmela Tartaglia,The ConversationCredit: AI-generated imageImagine you tell your 55 year-old mom you're going to get married and she's too disorganized to help you with the wedding p

Updated on: March 13,2024

Is that 'midlife crisis' really Alzheimer's disease?

by Carmela Tartaglia,The ConversationCredit: AI-generated imageImagine you tell your 55 year-old mom you're going to get married and she's too disorganized to help you with the wedding p

Updated on:March 13,2024

Silent synapses are abundant in the adult brain

by Anne Trafton,Massachusetts Institute of TechnologyCredit: Pixabay/CC0 Public DomainMIT neuroscientists have discovered that the adult brain contains millions of "silent synapses"—im

Updated on: February 05,2024

Silent synapses are abundant in the adult brain

by Anne Trafton,Massachusetts Institute of TechnologyCredit: Pixabay/CC0 Public DomainMIT neuroscientists have discovered that the adult brain contains millions of "silent synapses"—im

Updated on:February 05,2024

One in three people born in 2015 will develop dementia, new analysis shows

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Alzheimer's Research UK has renewed its call for urgent action on

Updated on: February 26,2024

One in three people born in 2015 will develop dementia, new analysis shows

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Alzheimer's Research UK has renewed its call for urgent action on

Updated on:February 26,2024

New blood test for Alzheimer's developed

by Margareta G. Kubista,University of GothenburgCredit: CC0 Public DomainA new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of

Updated on: April 18,2024

New blood test for Alzheimer's developed

by Margareta G. Kubista,University of GothenburgCredit: CC0 Public DomainA new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of

Updated on:April 18,2024

Can robots help care for people with dementia?

by George Wigmore,City University LondonCredit: AI-generated imageAs our populations continue to age the issue of how we deliver care to the elderly continues to be an incredibly important issue

Updated on: June 11,2024

Can robots help care for people with dementia?

by George Wigmore,City University LondonCredit: AI-generated imageAs our populations continue to age the issue of how we deliver care to the elderly continues to be an incredibly important issue

Updated on:June 11,2024

Record month for dementia diagnosis shows need for better tools, treatments

by Alzheimer's Research UKCredit: CC0 Public DomainAlzheimer's Research UK is calling for continued improvements in the way the UK diagnoses and treats dementia after a record number of p

Updated on: May 11,2024

Record month for dementia diagnosis shows need for better tools, treatments

by Alzheimer's Research UKCredit: CC0 Public DomainAlzheimer's Research UK is calling for continued improvements in the way the UK diagnoses and treats dementia after a record number of p

Updated on:May 11,2024

Unraveling the mysteries of the presynapse with super resolution microscopy

by Queensland Brain Institutea Graphical representation of the Dual-pulse sub-diffractional Tracking of Internalized Molecules (DsdTIM) protocol. b Representative epifluorescence image of an axonal se

Updated on: March 28,2024

Unraveling the mysteries of the presynapse with super resolution microscopy

by Queensland Brain Institutea Graphical representation of the Dual-pulse sub-diffractional Tracking of Internalized Molecules (DsdTIM) protocol. b Representative epifluorescence image of an axonal se

Updated on:March 28,2024

Brain mapping technique reveals insights into brain's higher functions

byUniversity of BirminghamHigher-order brain mapping: schematic of the approach and applications. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54472-yA new way of mapp

Updated on: December 17,2024

Brain mapping technique reveals insights into brain's higher functions

byUniversity of BirminghamHigher-order brain mapping: schematic of the approach and applications. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54472-yA new way of mapp

Updated on:December 17,2024

Dementia and COVID-19: Determinants of infection and mortality

by IOS PressFactors associated with 60-day mortality in dementia patients infected with SARS-CoV-2. Credit:Journal of Alzheimer's Disease(2022). DOI: 10.3233/JAD-220369The elderly

Updated on: May 06,2024

Dementia and COVID-19: Determinants of infection and mortality

by IOS PressFactors associated with 60-day mortality in dementia patients infected with SARS-CoV-2. Credit:Journal of Alzheimer's Disease(2022). DOI: 10.3233/JAD-220369The elderly

Updated on:May 06,2024

FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's disease

by American College of PhysiciansPET scan of a human brain with Alzheimer's disease. Credit: public domainDespite near unanimous objection from its advisory panel, the U.S. Food and Drug Admi

Updated on: March 30,2024

FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's disease

by American College of PhysiciansPET scan of a human brain with Alzheimer's disease. Credit: public domainDespite near unanimous objection from its advisory panel, the U.S. Food and Drug Admi

Updated on:March 30,2024

Vascular risk factors and Alzheimer's disease—a new therapeutic opportunity?

by IOS PressCurrently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment. Metaboli

Updated on: March 07,2024

Vascular risk factors and Alzheimer's disease—a new therapeutic opportunity?

by IOS PressCurrently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment. Metaboli

Updated on:March 07,2024